Protalix BioTherapeutics, Inc. News Headlines

PLX 
$3.44
*  
0.03
0.86%
Get PLX Alerts
*Delayed - data as of Jul. 28, 2014  -  Find a broker to begin trading PLX now
Exchange: AMEX
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Protalix Names Shlomo Yanai Chairman
7/24/2014 12:02:00 PM - RTT News

Pluristem Initiates Trial in South Korea - Analyst Blog
7/9/2014 6:00:00 PM - Zacks.com

Protalix Drug in Phase IIa Study for Gaucher Disease - Analyst Blog
6/19/2014 6:15:00 PM - Zacks.com

Protalix (PLX) in Focus: Stock Adds 6.5% in Session - Tale of the Tape
6/19/2014 9:25:00 AM - Zacks.com

Protalix To Present At Wells Fargo Conference; Webcast At 2:55 PM ET
6/17/2014 1:55:00 PM - RTT News

Protalix BioTherapeutics CEO David Aviezer To Retire - Quick Facts
6/13/2014 8:29:00 AM - RTT News

Protalix To Present At Jefferies Conference; Webcast At 4:00 PM ET
6/2/2014 3:00:00 PM - RTT News

Sector Update: Healthcare Shares Flat Pre-Market; Cytori Down 1% on Plans to Sell 4 Mln Units
5/30/2014 8:24:03 AM - MT Newswires

Protalix's Gaucher Drug ELELYSO Gets Approval In Canada
5/30/2014 8:05:00 AM - RTT News

EDAP Confirms FDA Panel Date, ISIS Reports Data, RedHill Touches New Peak
5/23/2014 2:27:00 AM - RTT News

Sector Update: Healthcare Shares Edging Higher in Pre-Bell Trade
3/6/2014 9:46:54 AM - MT Newswires

Sector Update: Healthcare
3/6/2014 9:45:13 AM - MT Newswires

Protalix Biotherapeutics - A Compelling Buy Due To Validation Of Oral Protein Delivery Technology
2/13/2014 11:33:00 AM - Seeking Alpha

Idenix Pharmaceuticals (IDIX) Soars: Stock Adds 18.2% in Session - Tale of the Tape
12/26/2013 10:11:01 AM - Zacks.com

Protalix BioTherapeutics Inc. Enters Oversold Territory - Tale of the Tape
11/27/2013 8:06:15 AM - Zacks.com

Will Omnivision (OVTI) Beat Earnings Estimates? - Analyst Blog
11/25/2013 11:00:01 AM - Zacks.com

Maxim Prices Senior Notes - Analyst Blog
11/18/2013 3:06:19 PM - Zacks.com

Protalix: Undervalued Growth, Plus A Possible Biotech Breakthrough
10/30/2013 5:29:00 PM - Seeking Alpha

Encouraging Data on Protalix Candidate - Analyst Blog
10/15/2013 5:50:01 PM - Zacks.com

Pipeline Progress at Pluristem - Analyst Blog
10/3/2013 2:30:01 PM - Zacks.com

Protalix Raises Funds - Analyst Blog
9/19/2013 7:26:01 PM - Zacks.com

Good News for Pluristem, Shares Up - Analyst Blog
9/17/2013 5:58:08 PM - Zacks.com

Protalix Prices Notes - Analyst Blog
9/13/2013 5:57:42 PM - Zacks.com

New Picks From The Hot Biotech IPO Market: Ran Nussbaum
8/23/2013 9:14:00 AM - Seeking Alpha

New Data on Biogen's Eloctate - Analyst Blog
7/8/2013 4:55:01 PM - Zacks.com